2023 Dalton Horizon Prize
Bismuth cure for COVID-19
Awarded for pioneering research on the medicinal chemistry of bismuth applied to the treatment of COVID-19, and identification of target sites in SARS-CoV-2 enzymes using metallomics methods.
Bismuth cure for COVID-19 is a multidisciplinary team from Hong Kong, consisting of chemists, microbiologists, and clinicians, that has been working together on the potential of bismuth drugs in the fight against COVID-19. Their work is based on their unique knowledge of bismuth chemistry as well as an integrative metallomics approach.
See full profile